The Non-Surgical Orbera Procedure is Here.
What is it?
The ORBERA Intragastric Balloon System is a weight-reduction treatment that uses a gastric balloon occupying space in the stomach.
The balloon is placed into the stomach through the mouth, using a minimally invasive endoscopic procedure, while the patient is under mild sedation. After placement, the balloon is filled with salt water (saline) so that it expands into a spherical shape.
The balloon is filled with different amounts of saline (from 400 to 700 cc) to best match the patient’s body structure.
How does it work?
The ORBERA Intragastric Balloon System takes up space in the stomach to help patients lose weight. The system is temporary and should be removed after six months.
The Orbera Procedure
The system is used in overweight adults who have a Body Mass Index (BMI) of 30-40 kg/m2 who have been unable to lose weight or maintain weightloss through tradition exercise and diet methods. However, it will be used while a patient also participates in a diet and exercise plan supervised by their healthcare professional.
What will it accomplish?
During the clinical study, the group of people who used the ORBERA Intragastric Balloon lost more weight on average than those who did not. The study follwed 255 patients for one year. During that period, 125 patients received the device and had it in place for six months. After the device was removed, they were followed for an additional six months. 130 patients participated in a 12-month behavior modification program and did not receive the device.
Patients with ORBERA lost an average of 21.8 pounds (10.2% of their body weight) after the device had been in place for six months. Three months after the device was removed (9 months after device placement), patients who received the device maintained an average of 19.4 pounds weight loss. The 130 patients who participated in the behavior modification program but did not receive the device lost an average of 7.0 pounds (3.3% of their body weight).
The device should not be used in patients who:
- already have an intragastric balloon
- have had prior gastrointestinal or bariatric surgery
- have any inflammatory disease of the gastrointestinal tract
- have potential upper gastrointestinal bleeding conditions
- have a large hiatal hernia
- have a structural abnormality in the esophagus or pharynx
- have serious esophageal motility disorders
- have a gastric mass
- have liver failure or cirrhosis
- have any other medical condition which would not permit elective endoscopy
- have a serious prior or present psychiatric illness
- have alcoholism or drug addiction
- who are unable or unwilling to take prescribed medication for the duration of the device implant
- are unable or unwilling to participate in a medically supervised diet and behavior modification program
- are receiving aspirin, anti-inflammatory agents, blood thinners (anticoagulants) or other gastric irritants
- are pregnant or breast-feeding
Dr. Adam Smith has been chosen by Apollo to be a spokesperson for the Orbera balloon. He is one of the first doctors in Texas that has been trained to use the device. Dr. Smith is not only able to understand the importance weight loss can have in a person’s life on a professional level, but on a personal one as well. In 2002, Dr. Smith underwent Lap-Band surgery, and was able to lose 100 lbs. The Lap-Band is also a product of Apollo, and is one Dr. Smith often recommends to patients who have more than 30 lbs. to lose. In his ongoing quest to stand up for the rights of the obese population, Dr. Smith was appointed as a spokesperson by the Obesity Action Coalition and Allergan as a part of the Voice my C.H.O.I.C.E. campaign, he served as the President of the American College of Osteopathic Surgeons in 2013, and is a member of many professional medical societies.
* Results may vary from person to person.